Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications

Biochimie

Volumn 93, Issue 1, 2011, Pages 46-51

  Aïd, Saba ^a   Bosetti, Francesca ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Brain; Cyclooxygenase; Microglia; Neuroinflammation; Neuroprotection; Prostanoids

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DEMENTIA; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME INHIBITION; GASTROINTESTINAL TOXICITY; HUMAN; LOW DRUG DOSE; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; REVIEW;

ANIMALS; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; NEURODEGENERATIVE DISEASES; PROSTAGLANDINS; RATS;

EID: 78650510200     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.09.009     Document Type: Review

References (55)

1. B. Kis, J.A. Snipes, and D.W. Busija Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties J. Pharmacol. Exp. Ther. 315 2005 1 7
2. M.K. O'Banion Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology Crit. Rev. Neurobiol. 13 1999 45 82
3. I. Morita Distinct functions of COX-1 and COX-2 Prostaglandins Other Lipid Mediat. 68-69 2002 165 175
4. Y.J. Kang, U.R. Mbonye, C.J. DeLong, M. Wada, and W.L. Smith Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation Prog. Lipid Res. 46 2007 108 125
5. C.D. Funk, and G.A. FitzGerald COX-2 inhibitors and cardiovascular risk J. Cardiovasc. Pharmacol. 50 2007 470 479
6. J.J. Hoozemans, A.J. Rozemuller, I. Janssen, C.J. De Groot, R. Veerhuis, and P. Eikelenboom Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain Acta Neuropathol. (Berl.) 101 2001 2 8
7. B. Garcia-Bueno, J. Serrats, and P.E. Sawchenko Cerebrovascular cyclooxygenase-1 expression, regulation, and role in hypothalamic-pituitary- adrenal axis activation by inflammatory stimuli J. Neurosci. 29 2009 12970 12981
8. A.V. Yermakova, J. Rollins, L.M. Callahan, J. Rogers, and M.K. O'Banion Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons J. Neuropathol. Exp. Neurol. 58 1999 1135 1146
9. H. Wang, I.M. Hitron, C. Iadecola, and V.M. Pickel Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex Cereb. Cortex 15 2005 1250 1260
10. B. Stefanovic, F. Bosetti, and A.C. Silva Modulatory role of cyclooxygenase-2 in cerebrovascular coupling Neuroimage 32 2006 23 32
11. S.J. Hewett, S.C. Bell, and J.A. Hewett Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system Pharmacol. Ther. 112 2006 335 357
12. K.A. Slanina, and P. Schweitzer Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus Neuropharmacology 49 2005 653 659
13. T.R. Cowley, B. Fahey, and S.M. O'Mara COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo Eur. J. Neurosci. 27 2008 2999 3008
14. F. Bosetti Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models J. Neurochem. 102 2007 577 586
15. D.W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark, and D.A. Willoughby Inducible cyclooxygenase may have anti-inflammatory properties Nat. Med. 5 1999 698 701
16. S.H. Choi, S. Aid, U. Choi, and F. Bosetti Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain Pharmacogenomics J. 2009
17. S. Aid, A.C. Silva, E. Candelario-Jalil, S.H. Choi, G.A. Rosenberg, and F. Bosetti Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide- induced blood-brain barrier disruption through matrix metalloproteinase activity J. Cereb. Blood Flow Metab. 30 2010 370 380
18. V. Blais, N.P. Turrin, and S. Rivest Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli J. Neurochem. 95 2005 1563 1574
19. J. Tuo, N. Tuaillon, D. Shen, and C.C. Chan Endotoxin-induced uveitis in cyclooxygenase-2-deficient mice Invest. Ophthalmol. Vis. Sci. 45 2004 2306 2313
20. S. Aid, R. Langenbach, and F. Bosetti Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2 J. Neuroinflammation [Electron. Resour.] 5 2008 17
21. R.H. Bonow, S. Aid, Y. Zhang, K.G. Becker, and F. Bosetti The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice Pharmacogenomics J. 9 2009 116 126
22. C.D. Keene, R. Chang, C. Stephen, M. Nivison, S.E. Nutt, A. Look, R.M. Breyer, P.J. Horner, R. Hevner, and T.J. Montine Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2 Am. J. Pathol. 174 2009 2300 2309
23. S. Lehnardt, L. Massillon, P. Follett, F.E. Jensen, R. Ratan, P.A. Rosenberg, J.J. Volpe, and T. Vartanian Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc. Natl. Acad. Sci. U.S.A. 100 2003 8514 8519
24. S.H. Choi, R. Langenbach, and F. Bosetti Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide- induced inflammatory response and brain injury FASEB J. 22 2008 1491 1501
25. E. Candelario-Jalil, and B.L. Fiebich Cyclooxygenase inhibition in ischemic brain injury Curr. Pharm. Des. 14 2008 1401 1418
26. P. Teismann, K. Tieu, D.K. Choi, D.C. Wu, A. Naini, S. Hunot, M. Vila, V. Jackson-Lewis, and S. Przedborski Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration Proc. Natl. Acad. Sci. U.S.A. 100 2003 5473 5478
27. S. Aid, N. Parikh, S. Palumbo, and F. Bosetti Neuronal overexpression of cyclooxygenase-2 does not alter the neuroinflammatory response during brain innate immune activation Neurosci. Lett. 478 2010 113 118
28. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat. Rev. Immunol. 8 2008 349 361
29. T. Lawrence, D.A. Willoughby, and D.W. Gilroy Anti-inflammatory lipid mediators and insights into the resolution of inflammation Nat. Rev. Immunol. 2 2002 787 795
30. C.N. Serhan, S. Yacoubian, and R. Yang Anti-inflammatory and proresolving lipid mediators Annu. Rev. Pathol. 3 2008 279 312
31. J.M. Schwab, N. Chiang, M. Arita, and C.N. Serhan Resolvin E1 and protectin D1 activate inflammation-resolution programmes Nature 447 2007 869 874
32. M.M. Chan, A.R. Moore, Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production, J. Immunol. 184, 6418-6426.
33. D.W. Gilroy, P.R. Colville-Nash, S. McMaster, D.A. Sawatzky, D.A. Willoughby, and T. Lawrence Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis Faseb J. 17 2003 2269 2271
34. A.L. Groeger, C. Cipollina, M.P. Cole, S.R. Woodcock, G. Bonacci, T.K. Rudolph, V. Rudolph, B.A. Freeman, F.J. Schopfer, Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids, Nat. Chem. Biol. 6, 433-441.
35. N.G. Bazan Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors Trends Neurosci. 29 2006 263 271
36. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037
37. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
38. S. Hong, K. Gronert, P.R. Devchand, R.L. Moussignac, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J. Biol. Chem. 278 2003 14677 14687
39. T.D. Niemoller, D.T. Stark, and N.G. Bazan Omega-3 fatty acid docosahexaenoic acid is the precursor of neuroprotectin D1 in the nervous system World Rev. Nutr. Diet 99 2009 46 54
40. P.C. Calder Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale Biochimie 91 2009 791 795
41. S.H. Choi, S. Aid, and F. Bosetti The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research Trends Pharmacol. Sci. 30 2009 174 181
42. S.H. Choi, and F. Bosetti Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid Aging (Albany, NY) 1 2009 234 244
43. S.B. Matousek, A.M. Hein, S.S. Shaftel, J.A. Olschowka, S. Kyrkanides, M.K. O'Banion, Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression, J. Neurochem. 114, 247-258.
44. X.L. Gu, C.X. Long, L. Sun, C. Xie, X. Lin, H. Cai, Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice, Mol. Brain 3, 12.
45. E. Candelario-Jalil, S. Taheri, Y. Yang, R. Sood, M. Grossetete, E.Y. Estrada, B.L. Fiebich, and G.A. Rosenberg Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat J. Pharmacol. Exp. Ther. 323 2007 488 498
46. P.L. McGeer, and E.G. McGeer NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies Neurobiol. Aging 28 2007 639 647
47. S.C. Vlad, D.R. Miller, N.W. Kowall, and D.T. Felson Protective effects of NSAIDs on the development of Alzheimer disease Neurology 70 2008 1672 1677
48. J. Rogers, L.C. Kirby, S.R. Hempelman, D.L. Berry, P.L. McGeer, A.W. Kaszniak, J. Zalinski, M. Cofield, L. Mansukhani, and P. Willson Clinical trial of indomethacin in Alzheimer's disease Neurology 43 1993 1609 1611
49. A.R. Group, C.G. Lyketsos, J.C. Breitner, R.C. Green, B.K. Martin, C. Meinert, S. Piantadosi, and M. Sabbagh Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial Neurology 68 2007 1800 1808
50. B.K. Martin, C. Szekely, J. Brandt, S. Piantadosi, J.C. Breitner, S. Craft, D. Evans, R. Green, and M. Mullan Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib Arch. Neurol. 65 2008 896 905
51. J.L. Wallace, W. McKnight, B.K. Reuter, and N. Vergnolle NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2 Gastroenterology 119 2000 706 714
52. A. Tanaka, S. Hase, T. Miyazawa, R. Ohno, and K. Takeuchi Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events J. Pharmacol. Exp. Ther. 303 2002 1248 1254
53. A. Menozzi, C. Pozzoli, E. Giovannini, E. Solenghi, D. Grandi, S. Bonardi, S. Bertini, V. Vasina, and G. Coruzzi Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat Eur. J. Pharmacol. 552 2006 143 150
54. P. Bentham, R. Gray, E. Sellwood, R. Hills, P. Crome, and J. Raftery Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial Lancet Neurol. 7 2008 41 49
55. J.M. Scheiman NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management Dig. Dis. 12 1994 210 222